Phase II study of intraperitoneal submicron particle paclitaxel (SPP) plus IV carboplatin and paclitaxel in patients with epithelial ovarian cancersurgery

Submicron particles (~800 nm) of paclitaxel (SPP) contain 1–2 billion molecules of pure drug that release tumoricidal levels of paclitaxel over many weeks. This study compared two dose-levels of SPP instilled into the peritoneal cavity (IP) in 200 ml of saline post-cytoreductive surgery. Eligible pa...

Full beskrivning

Bibliografiska uppgifter

Huvudupphov:	Sally Mullany, David Scott Miller, Katina Robison, Kimberly Levinson, Yi-Chun Lee, S. Diane Yamada, Joan Walker, Maurie Markman, Alyson Marin, Peter Mast, Gere diZerega
Materialtyp:	Artigo
Språk:	Inglês
Utgiven:	Elsevier 2020-11-01
Serie:	Gynecologic Oncology Reports
Ämnen:	Ovarian cancer Paclitaxel Intraperitoneal therapy NanoPac Submicron particle paclitaxel
Länkar:	http://www.sciencedirect.com/science/article/pii/S235257892030093X
Taggar:	Lägg till en tagg Inga taggar, Lägg till första taggen!